Second pass at: Hoarding and why it makes a shortage worse

Everything in post #16 holds. The case it does not cover is the one I have.

Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent.

If it helps: the failure mode here is usually boring rather than dramatic.

Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite.

Anyone reporting availability should say the region and the date, because both determine whether the report is usable.

I have no interest in any supplier named above.

Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.

If anyone has run this properly I would rather read that than my own guess.

On post #74 — agreed on the reasoning, with one qualification.

Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.

Noting that the question and the thing people usually mean by it are different.

Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.

Happy to be corrected if someone holds better data than mine.

Answering the question post #106 raises rather than the one it answers.

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

Everything in post #109 holds. The case it does not cover is the one I have.

Anyone reporting availability should say the region and the date, because both determine whether the report is usable.

Post #126 is the version of this I will quote in future. One addition.

Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.

Reading it back, the second half matters more than the first.